Buggert, Marcus http://orcid.org/0000-0003-0633-1719
Price, David A. http://orcid.org/0000-0001-9416-2737
Mackay, Laura K. http://orcid.org/0000-0002-8496-6632
Betts, Michael R. http://orcid.org/0000-0002-7690-1484
Article History
Received: 10 March 2023
Accepted: 4 May 2023
First Online: 22 June 2023
Change Date: 17 July 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41590-023-01586-y
Competing interests
: M.B. is a consultant for Oxford Immunotec, Mabtech, Pfizer, BMS and MSD. M.R.B. is a consultant for Interius Biotherapeutics. D.A.P. and L.K.M. declare no competing interests.